Dolutegravir monotherapy as a simplified strategy in virologically suppressed HIV-1-infected patients

dc.creatorMoreira, José
dc.date2019-02-12T13:53:00Z
dc.date2019-02-12T13:53:00Z
dc.date2016
dc.date.accessioned2023-09-26T20:19:31Z
dc.date.available2023-09-26T20:19:31Z
dc.identifierMOREIRA, José. Dolutegravir monotherapy as a simplified strategy in virologically suppressed HIV-1-infected patients. Journal of Antimicrobial Chemotherapy, v. 71, n. 9, p. 2675-2676, 2016.
dc.identifier0305-7453
dc.identifierhttps://www.arca.fiocruz.br/handle/icict/31573
dc.identifier10.1093/jac/dkw154
dc.identifier1460-2091
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/8854266
dc.formatapplication/pdf
dc.languageeng
dc.publisherOxford University Press
dc.rightsopen access
dc.subjectDolutegravir
dc.subjectHIV-1
dc.subjectHIV-1-infected patients
dc.titleDolutegravir monotherapy as a simplified strategy in virologically suppressed HIV-1-infected patients
dc.typeArticle


Este ítem pertenece a la siguiente institución